MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

Evolent Health Inc

Închisă

SectorSănătate

2.85 -4.04

Rezumat

Modificarea prețului

24h

Curent

Minim

2.84

Maxim

2.89

Indicatori cheie

By Trading Economics

Venit

-408M

-429M

Vânzări

-11M

469M

Marjă de profit

-91.554

Angajați

4,200

EBITDA

-374M

-360M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+80.99% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-39M

282M

Deschiderea anterioară

6.89

Închiderea anterioară

2.85

Sentimentul știrilor

By Acuity

50%

50%

150 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

Evolent Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 apr. 2026, 20:26 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 apr. 2026, 18:15 UTC

Evenimente importante

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

18 apr. 2026, 01:00 UTC

Evenimente importante

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 apr. 2026, 22:58 UTC

Câștiguri

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr. 2026, 20:52 UTC

Câștiguri

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr. 2026, 20:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 apr. 2026, 20:29 UTC

Câștiguri

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 apr. 2026, 19:31 UTC

Market Talk
Evenimente importante

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17 apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 apr. 2026, 18:57 UTC

Evenimente importante

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB 2026 Rev Guidance Unchanged

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 apr. 2026, 18:14 UTC

Market Talk
Evenimente importante

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 apr. 2026, 17:31 UTC

Market Talk
Evenimente importante

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 apr. 2026, 17:26 UTC

Market Talk
Câștiguri

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparație

Modificare preț

Evolent Health Inc Așteptări

Obiectiv de preț

By TipRanks

80.99% sus

Prognoză pe 12 luni

Medie 5.14 USD  80.99%

Maxim 8 USD

Minim 3 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEvolent Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

14 ratings

12

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

10.33 / 10.95Suport & Rezistență

Termen scurt

Very Strong Bullish Evidence

Termen mediu

Very Strong Bullish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

150 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat